News

Public · Published

Key facts: Surgery Partners rejects $28 bid; UnitedHealth names Bell

UnitedHealth Group offered $28 per share to acquire Surgery Partners, which rejected the unsolicited bid, citing deal complexity and concerns about closing. UnitedHealth also appointed Madeline S. Bell, former CEO of Children's Hospital of Philadelphia, as an independent director effective November 3, 2026; she has four decades of health care experience.

Published:

Updated:

What happened

UnitedHealth Group offered $28 per share to acquire Surgery Partners, which rejected the unsolicited bid, citing deal complexity and concerns about closing. UnitedHealth also appointed Madeline S. Bell, former CEO of Children’s Hospital of Philadelphia, as an independent director effective November 3, 2026; she has four decades of health care experience.

Confirmed

Global impact / market context

The rejected offer leaves the proposed acquisition unresolved, so UnitedHealth does not gain Surgery Partners through this bid and the companies avoid an immediate ownership change. Bell’s appointment adds health care experience to UnitedHealth’s board, but the supplied information does not establish any resulting change to strategy or financial performance.

Analyst inference

The article gives no share-price reaction, financing details, or revised offer. The $28-per-share bid is therefore the only stated transaction reference, while Surgery Partners’ concerns about complexity and closing indicate that deal completion—not just price—was an obstacle.

Analyst inference

What to watch

  1. Watch for any new UnitedHealth offer or further company statement; the article reports a rejection but does not say whether negotiations will continue. Analyst inference
  2. Look for clarification from Surgery Partners on the cited closing concerns, since unresolved approval or execution issues could prevent a transaction even at an agreed price. Analyst inference
  3. Bell’s board role is scheduled to begin November 3, 2026; subsequent company disclosures could show whether her appointment informs board oversight or decisions. Confirmed

Evidence

  • Original source link unavailable